AstraZeneca/$AZN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About AstraZeneca
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Ticker
$AZN
Sector
Primary listing
NYSE
Employees
96,100
Headquarters
Website
AstraZeneca Metrics
BasicAdvanced
$283bn
27.63
$6.64
0.28
$3.20
2.37%
Price and volume
Market cap
$283bn
Beta
0.28
52-week high
$212.71
52-week low
$181.73
Average daily volume
2m
Dividend rate
$3.20
Financial strength
Current ratio
0.909
Quick ratio
0.701
Long term debt to equity
54.801
Total debt to equity
71.815
Dividend payout ratio (TTM)
46.07%
Interest coverage (TTM)
10.59%
Profitability
EBITDA (TTM)
19,994
Gross margin (TTM)
81.51%
Net profit margin (TTM)
17.19%
Operating margin (TTM)
24.69%
Effective tax rate (TTM)
19.52%
Revenue per employee (TTM)
$630,000
Management effectiveness
Return on assets (TTM)
8.47%
Return on equity (TTM)
23.48%
Valuation
Price to earnings (TTM)
27.63
Price to revenue (TTM)
4.704
Price to book
4.42
Price to tangible book (TTM)
-19.44
Price to free cash flow (TTM)
35.903
Free cash flow yield (TTM)
2.79%
Free cash flow per share (TTM)
5.11
Dividend yield (TTM)
1.74%
Forward dividend yield
2.37%
Growth
Revenue change (TTM)
9.93%
Earnings per share change (TTM)
33.61%
3-year revenue growth (CAGR)
11.30%
10-year revenue growth (CAGR)
9.33%
3-year earnings per share growth (CAGR)
30.03%
10-year earnings per share growth (CAGR)
11.18%
3-year dividend per share growth (CAGR)
3.34%
10-year dividend per share growth (CAGR)
1.34%
AstraZeneca News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for AstraZeneca stock?
AstraZeneca (AZN) has a market cap of $283B as of May 05, 2026.
What is the P/E ratio for AstraZeneca stock?
The price to earnings (P/E) ratio for AstraZeneca (AZN) stock is 27.63 as of May 05, 2026.
Does AstraZeneca stock pay dividends?
Yes, the AstraZeneca (AZN) stock pays dividends to shareholders. As of May 05, 2026, the dividend rate is $3.2 and the yield is 2.37%. AstraZeneca has a payout ratio of 46.07% on a trailing twelve-month basis.
When is the next AstraZeneca dividend payment date?
The next AstraZeneca (AZN) dividend payment date is unconfirmed.
What is the beta indicator for AstraZeneca?
AstraZeneca (AZN) has a beta rating of 0.28. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.